1. ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer. Issue 3 (11th February 2020) Authors: Kawakami, Ryuhei; Mashima, Tetsuo; Kawata, Naomi; Kumagai, Koshi; Migita, Toshiro; Sano, Takeshi; Mizunuma, Nobuyuki; Yamaguchi, Kensei; Seimiya, Hiroyuki Journal: Cancer science Issue: Volume 111:Issue 3(2020) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation. Issue 7 (25th May 2015) Authors: Mashima, Tetsuo; Ushijima, Masaru; Matsuura, Masaaki; Tsukahara, Satomi; Kunimasa, Kazuhiro; Furuno, Aki; Saito, Sakae; Kitamura, Masami; Soma‐Nagae, Taeko; Seimiya, Hiroyuki; Dan, Shingo; Yamori, Takao; Tomida, Akihiro Journal: Cancer science Issue: Volume 106:Issue 7(2015:Jul.) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation. Issue 7 (25th May 2015) Authors: Mashima, Tetsuo; Ushijima, Masaru; Matsuura, Masaaki; Tsukahara, Satomi; Kunimasa, Kazuhiro; Furuno, Aki; Saito, Sakae; Kitamura, Masami; Soma‐Nagae, Taeko; Seimiya, Hiroyuki; Dan, Shingo; Yamori, Takao; Tomida, Akihiro Journal: Cancer science Issue: Volume 106:Issue 7(2015:Jul.) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of a gene expression database and related analysis programs for evaluation of anticancer compounds. Issue 3 (4th January 2013) Authors: Ushijima, Masaru; Mashima, Tetsuo; Tomida, Akihiro; Dan, Shingo; Saito, Sakae; Furuno, Aki; Tsukahara, Satomi; Seimiya, Hiroyuki; Yamori, Takao; Matsuura, Masaaki Journal: Cancer science Issue: Volume 104:Issue 3(2013:Mar.) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib. Issue 2 (27th January 2020) Authors: Matsusaka, Satoshi; Hanna, Diana L.; Ning, Yan; Yang, Dongyun; Cao, Shu; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Dan, Shingo; Mashima, Tetsuo; Seimiya, Hiroyuki; Zhang, Wu; Lenz, Heinz‐Josef Journal: Cancer science Issue: Volume 111:Issue 2(2020) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor. Issue 5 (24th March 2021) Authors: Nishiya, Naoyuki; Oku, Yusuke; Ishikawa, Chie; Fukuda, Tsutomu; Dan, Shingo; Mashima, Tetsuo; Ushijima, Masaru; Furukawa, Yoko; Sasaki, Yuka; Otsu, Keishi; Sakyo, Tomoko; Abe, Masanori; Yonezawa, Honami; Ishibashi, Fumito; Matsuura, Masaaki; Tomida, Akihiro; Seimiya, Hiroyuki; Yamori, Takao; Iwao... Journal: Cancer science Issue: Volume 112:Issue 5(2021) Page Start: 1963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer. Issue 8 (13th July 2018) Authors: Osumi, Hiroki; Shinozaki, Eiji; Mashima, Tetsuo; Wakatsuki, Takeru; Suenaga, Mitsukuni; Ichimura, Takashi; Ogura, Mariko; Ota, Yumiko; Nakayama, Izuma; Takahari, Daisuke; Chin, Keisho; Miki, Yoshio; Yamaguchi, Kensei Journal: Cancer science Issue: Volume 109:Issue 8(2018) Page Start: 2567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗